Dear Sir:
I read with interest the findings of Jarjou et al (1) on infants born to a subset of 8325 women randomly assigned during pregnancy to test the effect of calcium on the prevention of preeclampsia (2) . Methodologic and clinical issues exist that may shed light on the appropriate interpretation of the data in this report.
It is well known in adults that the usefulness of single-photon absorptiometry measurement as an indicator of total-body bone accretion is limited. We showed in infants that regional bone mass measurements vary with gestational and postnatal age and are not comparable with changes in total-body bone mass accretion (3, 4) ; thus, the data on bone accretion are best determined by total-body bone mass by dual-energy X-ray absorptiometry (DXA). One major concern with this report (1) is that complete DXA measurements of total-body bone mass were available in 18% of the subjects (9 infants in the supplemented group and 11 in the placebo group) and DXA measurements at any single time point were available in 45% of the subjects. The other major concern is the lack of peer reviewed data validating the type of DXA densitometer used for the study of subjects weighing 5-15 kg (1) . In addition, the DXA densitometer used in this study was not recommended for subjects weighing 5 kg, which included all of the infants studied at 2 wk and many infants studied at 13 wk.
DXA has its limitations, including hardware and software differences among different manufacturers and even among densitometers from the same manufacturer. However, the authors' sweeping statement that DXA scanning in infants is a "largely unvalidated technique" is unjustified concerning the measurement of bone mass and body composition in small subjects. Specifically, we (5, 6) and 2 other groups (7, 8) have independently validated the use of several different pencil-beam DXA densitometer models from one manufacturer (Hologic Inc, Bedford, MA) for the measurement of bone mass and body composition based on piglet carcass, across the weight range 0.6 -21.1 kg, with chemical analysis and multiple other techniques. In addition, we have modified the commercial software for the fan/cone beam DXA from the same manufacturer to validate its use over the same range of animal weights (9, 10) . Almost 300 reports of DXA studies in infants and 100 reports in neonates are now available; thus, Table 5 in the article by Jarjou et al (1) grossly underrepresents the data in the literature.
Bone mineralization does not depend on the availability of calcium alone. The availability of protein, energy, and many other nutrients also is important to bone formation and bone mineralization. Our report on the beneficial effect of bone mass accretion in the fetus after calcium supplementation during pregnancy was applicable to women who had low dietary calcium intakes (mean intake: 411 mg/d) but who were otherwise adequately nourished, specifically with protein and energy (11) . Inadequate maternal intake of other nutrients, particularly protein and energy, during pregnancy presumably occurred in many of the mothers of the infants studied (1), which may have countered any beneficial effect of maternal calcium supplementation. Postnatal nutritional deficiency, including deficiencies in protein, energy, and of nutrients other than calcium, also can affect skeletal growth. Do the authors have information on the protein and energy intakes of the mothers during pregnancy and lactation and of the infants?
No conflicts of interest were reported.
Winston Koo
Hutzel Women's Hospital Department of Pediatrics 3980 John R Detroit, MI 48201 E-mail: wkoo@wayne.edu
